Literature DB >> 20174989

Renal disease in systemic sclerosis with normal serum creatinine.

Reem H A Mohamed1, Hania S Zayed, Amr Amin.   

Abstract

Prognosis of systemic sclerosis largely depends on involvement of internal organs. The aim was to evaluate renal impairment in patients with systemic sclerosis by measuring the Glomerular filteration rate (GFR) and then calculating the GFR using the Cockgroft and Gault formula and the Modification of Diet in Renal Disease Equation (MDRD) formula. Thirty one scleroderma patients were recruited from the Rheumatology and Rehabilitation Department, Cairo University Hospitals, mean age 43.25 +/- 11.28 years, 31 healthy controls were included. Disease severity was done using Medsger score. GFR was measured using classical Gates method TC99mDTPA. The modified Cockcroft and Gault formula and equation 7 from the MDRD were used for calculation of GFR. All patients had within normal serum creatinine levels. A normal GFR (>89ml/min) was found in 45.1%. Gates method showed reduced GFR was reported in 54.9%. Stage II chronic kidney disease (60-89 ml/min) found 32.3%, and stage III (30-59 ml/min) in 22.6%. The formulae used showed reduction of GFR in 35.29% of those affected by the Cockcroft-Gault and in 41.17% of those affected using the MDRD. No correlation to patients' age, disease duration, or severity. A positive correlation was also reported between the presence of renal involvement and pulmonary vascular involvement p = 0.04. Gates method showed reduction of the GFR in 54.9% of the systemic sclerosis patients. The formulae used were not as precise as the measured GFR in diagnosing all cases with subclinical renal involvement. Patients with systemic sclerosis should be screened for renal involvement irrespective of disease severity or duration.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20174989     DOI: 10.1007/s10067-010-1389-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  45 in total

1.  Isotopic scan for diagnosis of renal disease.

Authors:  Yusuke Inoue; Manabu Minami; Kuni Ohtomo
Journal:  Saudi J Kidney Dis Transpl       Date:  2004 Jul-Sep

2.  An epidemiological study of scleroderma in the West Midlands.

Authors:  A Silman; S Jannini; D Symmons; P Bacon
Journal:  Br J Rheumatol       Date:  1988-08

3.  Endogenous creatinine clearance in apparently healthy individuals as determined by 24 hour ambulatory urine collection.

Authors:  L Wibell; E Björsell-Ostling
Journal:  Ups J Med Sci       Date:  1973       Impact factor: 2.384

4.  Dietary treatment of chronic renal failure: ten unanswered questions.

Authors:  A M el Nahas; G A Coles
Journal:  Lancet       Date:  1986-03-15       Impact factor: 79.321

Review 5.  Epidemiology and natural history of systemic sclerosis.

Authors:  V D Steen; T A Medsger
Journal:  Rheum Dis Clin North Am       Date:  1990-02       Impact factor: 2.670

Review 6.  Scleroderma--demographics and survival.

Authors:  A J Silman
Journal:  J Rheumatol Suppl       Date:  1997-05

7.  Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults.

Authors:  G B Haycock; G J Schwartz; D H Wisotsky
Journal:  J Pediatr       Date:  1978-07       Impact factor: 4.406

8.  Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment.

Authors:  E J Kingdon; C J Knight; K Dustan; A G Irwin; M Thomas; S H Powis; A Burns; A J W Hilson; C M Black
Journal:  Rheumatology (Oxford)       Date:  2003-01       Impact factor: 7.580

9.  Prevalence of renal involvement in Indian patients with systemic sclerosis.

Authors:  R Gupta; C Bammigatti; A K Dinda; V Marwaha; S Gupta
Journal:  Indian J Med Sci       Date:  2007-02

10.  Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.

Authors:  Andriana I Papaioannou; Epaminondas Zakynthinos; Konstantinos Kostikas; Theodoros Kiropoulos; Angela Koutsokera; Athanasios Ziogas; Athanasios Koutroumpas; Lazaros Sakkas; Konstantinos I Gourgoulianis; Zoe D Daniil
Journal:  BMC Pulm Med       Date:  2009-05-09       Impact factor: 3.317

View more
  7 in total

1.  Tc-99m diethylenetriamine pentaacetic acid (DTPA) renal function reserve estimation: is it a reliable predictive tool for assessment of preclinical renal involvement in scleroderma patients?

Authors:  Amr Amin; S El-Sayed; N Taher; M Sedki; H Nasr
Journal:  Clin Rheumatol       Date:  2012-02-24       Impact factor: 2.980

2.  Arterial hypertension treated with angiotensin converting enzyme inhibitors and glucocorticoids are independent risk factors associated with decreased glomerular filtration rate in systemic sclerosis.

Authors:  Predrag Ostojic; Natasa Stojanovski
Journal:  Rheumatol Int       Date:  2016-12-22       Impact factor: 2.631

Review 3.  Scleroderma renal crisis and renal involvement in systemic sclerosis.

Authors:  Thasia G Woodworth; Yossra A Suliman; Wendi Li; Daniel E Furst; Philip Clements
Journal:  Nat Rev Nephrol       Date:  2016-09-19       Impact factor: 28.314

4.  Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-17

5.  Tc-99 m diethylenetriamine-pentaacetic acid (DTPA): is it reliable for assessment of methotrexate-induced cumulative effect on renal filtration in rheumatoid arthritis patients?

Authors:  Amr Amin; Dina Effat; Nabila Goher; Basma Ramadan
Journal:  Rheumatol Int       Date:  2012-12-23       Impact factor: 2.631

Review 6.  Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management.

Authors:  Victoria K Shanmugam; Virginia D Steen
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

7.  Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients - a 24-month observation.

Authors:  Ewa Wielosz; Maria Majdan; Arkadiusz Koszarny; Magdalena Dryglewska; Jacek Tabarkiewicz
Journal:  Cent Eur J Immunol       Date:  2017-08-08       Impact factor: 2.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.